Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PRLD |
---|---|---|
09:32 ET | 611 | 4.215 |
09:54 ET | 3290 | 3.995 |
09:56 ET | 2441 | 4.1 |
09:57 ET | 1569 | 4.08 |
09:59 ET | 1991 | 4.09 |
10:01 ET | 1786 | 3.95 |
10:06 ET | 300 | 4.07 |
10:12 ET | 100 | 4.005 |
10:17 ET | 100 | 4.005 |
10:21 ET | 642 | 4 |
10:24 ET | 220 | 4 |
10:26 ET | 733 | 4 |
10:46 ET | 100 | 3.945 |
10:51 ET | 5172 | 3.98 |
10:53 ET | 150 | 4.0179 |
10:57 ET | 100 | 3.92 |
11:00 ET | 400 | 3.92 |
11:04 ET | 1206 | 3.93 |
11:06 ET | 100 | 3.905 |
11:09 ET | 400 | 3.9 |
11:11 ET | 200 | 3.895 |
11:18 ET | 100 | 3.895 |
11:22 ET | 100 | 3.895 |
11:24 ET | 122 | 3.9 |
11:27 ET | 100 | 3.88 |
11:29 ET | 972 | 3.86 |
11:33 ET | 477 | 3.7052 |
11:36 ET | 3000 | 3.82 |
11:42 ET | 7500 | 3.7 |
11:44 ET | 200 | 3.765 |
11:45 ET | 110 | 3.765 |
11:47 ET | 168 | 3.765 |
11:51 ET | 118 | 3.77 |
11:54 ET | 500 | 3.8 |
12:00 ET | 257 | 3.7825 |
12:14 ET | 200 | 3.775 |
12:18 ET | 100 | 3.775 |
12:20 ET | 200 | 3.775 |
12:21 ET | 100 | 3.775 |
12:25 ET | 750 | 3.77 |
12:48 ET | 168 | 3.78 |
12:54 ET | 100 | 3.78 |
01:08 ET | 420 | 3.805 |
01:12 ET | 115 | 3.78 |
01:19 ET | 622 | 3.78 |
01:21 ET | 100 | 3.78 |
01:32 ET | 200 | 3.76 |
01:33 ET | 200 | 3.75 |
01:35 ET | 100 | 3.775 |
01:46 ET | 2955 | 3.81 |
01:51 ET | 780 | 3.805 |
01:57 ET | 100 | 3.8 |
02:08 ET | 1124 | 3.82 |
02:15 ET | 100 | 3.79 |
02:18 ET | 100 | 3.785 |
02:29 ET | 524 | 3.73 |
02:33 ET | 100 | 3.74 |
02:40 ET | 140 | 3.755 |
02:42 ET | 300 | 3.74 |
02:58 ET | 100 | 3.71 |
03:00 ET | 121 | 3.74 |
03:05 ET | 120 | 3.74 |
03:18 ET | 114 | 3.755 |
03:27 ET | 100 | 3.755 |
03:30 ET | 300 | 3.755 |
03:32 ET | 100 | 3.755 |
03:36 ET | 115 | 3.755 |
03:43 ET | 200 | 3.75 |
03:45 ET | 270 | 3.755 |
03:48 ET | 155 | 3.755 |
03:52 ET | 732 | 3.745 |
03:56 ET | 500 | 3.7479 |
03:57 ET | 404 | 3.7375 |
03:59 ET | 300 | 3.71 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Prelude Therapeutics Inc | 224.7M | -2.0x | --- |
Pyxis Oncology Inc | 224.4M | -2.7x | --- |
Rani Therapeutics Holdings Inc | 223.9M | -3.6x | --- |
Invivyd Inc | 230.3M | -0.9x | --- |
Candel Therapeutics Inc | 232.0M | -6.6x | --- |
Aldeyra Therapeutics Inc | 232.3M | -7.5x | --- |
Prelude Therapeutics Incorporated is a clinical-stage fully integrated oncology company built on a foundation of drug discovery to deliver novel precision cancer medicines to underserved patients. It has developed a diverse pipeline consisting of multiple distinct programs: kinases, targeted protein degraders, and precision antibody drug conjugates. Its product candidates include PRT3789, PRT2527 and PRT3645. PRT3789 is a highly selective degrader of SMARCA2 protein, which along with SMARCA4, controls gene regulation through chromatin remodeling. Its CDK9 program is an essential regulator of cancer-promoting transcriptional programs, including those driven by MCL1, MYC and MYB. PRT3645 is a brain and tissue penetrant molecule that potently targets CDK4/6 with a biased selectivity for CDK4. PRT2527 is designed to be a potent and selective CDK9 inhibitor. Its MCL1 candidate, PRT1419, is designed to be a potent and selective inhibitor of the anti-apoptotic protein, MCL1.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $224.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 54.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.57 |
EPS | $-1.88 |
Book Value | $4.32 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.